logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-8. New and all clients entering treatment for primary use of amphetamines, ecstasy and other non-cocaine stimulants in 2005 for countries supplying data [see all tables in this series...]

Part(i) All clients of all treatment centres reported for the country

CountryAmphetamines%Ecstasy%Other stimulants%Total
Bulgaria1184.6215.400.013
Czech Republic460899.3210.5110.24640
Denmark31388.24211.800.0355
Ireland3722.712677.300.0163
Greece00.0654.5545.511
Spain(1)31750.026441.6538.4634
France4218.318881.700.0230
Italy4912.634187.400.0390
Cyprus120.0480.000.05
Luxembourg426.71173.300.015
Hungary73950.059240.014810.01479
Malta00.05100.000.05
Netherlands45171.712219.4568.9629
Romania212.51487.500.016
Slovenia(1)333.3666.700.09
Slovakia49498.861.200.0500
Finland79396.500.0293.5822
Sweden236299.2200.800.02382
United Kingdom(2)373177.893719.51302.74798
Turkey21.811198.200.0113
Total1395981.1281816.44322.517209

Notes:

 Only countries supplying data were reported. 

 Percentage of drugs is percentage from all stimulants. 

 (1) Last data available refer to 2004. 

 (2) Data collection period refers to 01.04.2004 to 31.03.2005. 

 See also ''General notes for interpreting data'' on the Explanatory notes and help page

Sources:

 2006 Reitox national reports - ST03. 

Page last updated: Monday, 12 November 2007